Skip to main content

Medical Management of Obesity

  • Chapter
  • First Online:
Global Bariatric Surgery
  • 826 Accesses

Abstract

The genetic-environment combination is central to the genesis of obesity. Obesity emerged as one of the major health problems during the last century, from the enormous environmental changes that the world experienced. Environmental factors favoring a positive energy balance and weight gain include, on the one hand, increased availability of food, particularly high-calorie foods, and increased portion sizes and, on the other hand, decreased movement, with less time of physical activity at work and the replacement of physical activity in leisure time with sedentary activities such as watching TV and the use of electronic devices. Other factors considered to contribute to the obesity epidemic are use of drugs that have weight gain as a side effect, reduction in variability of ambient temperatures, sleep debt, increasing maternal age, greater fecundity among people with higher adiposity, assortative mating, endocrine disruptors, microorganisms, epigenetics, and intrauterine and intergenerational effects. These and many other factors, combined with medical innovations that have reduced mortality and prolonged life, laid the foundation for the obesity epidemic.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Popkin BM, Hawkes C. Sweetening of the global diet, particularly beverages: patterns, trends, and policy responses. Lancet Diabetes Endocrinol. 2016;4:174–86.

    Article  PubMed  Google Scholar 

  2. Church TS, Thomas DM, Tudor-Locke CT. Trends over 5 decades in U.S. occupation-related physical activity and their associations with obesity. PLoS One. 2011;6(5):e19657.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Mc Allister EJ, Dhurandhar N, Keith S. Ten putative contributors to the obesity epidemic. Crit Rev Food Sci Nutr. 2009;49:868–913.

    Article  Google Scholar 

  4. Allison DB, Downey M, Atkinson RL. Obesity as a disease: a white paper on evidence and arguments commissioned by the Council of the Obesity Society. Obesity (Silver Spring). 2008;16:1161–77.

    Article  Google Scholar 

  5. Garvey T, Mechanick JI, Brett EM. American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines for medical care of patients with obesity. Endocr Pract. 2016;22(Suppl 3):1–203.

    Article  PubMed  Google Scholar 

  6. Wadden TA, Butryn ML, Hong PS, Wadden TA. Behavioral treatment of obesity in patients encountered in primary care settings: a systematic review. JAMA. 2014;312:1779–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Antognoli EL, Seeholzer EL, Gullett H. Primary care resident training for obesity, nutrition, and physical activity counseling. Health Promot Pract. 2017;18(5):672–80.

    Article  PubMed  Google Scholar 

  8. Gudzune KA, Beach MC, Roter DL. Physicians build less rapport with obese patients. Obesity (Silver Spring). 2013;21(10):2146–52.

    Article  Google Scholar 

  9. Jensen MD, Ryan DH, Donato KA, Apovian CM, Ard JD, Comuzzie AG, Hu FB, Hubbard VS, Jakicic JM, Kushner RF, Loria CM, Millen BE, Nonas CA, Pi-Sunyer FX, Stevens J, Stevens VJ, Wadden TA, Wolfe BM, Yanovski SZ. Guidelines (2013) for managing overweight and obesity in adults. Obesity. 2014;22(S2):S1–S410.

    Article  Google Scholar 

  10. National Institute for Health and Care Excellence (UK). National Institute for Health and Clinical Excellence: guidance. Obesity: identification, assessment and management of overweight and obesity in children, young people and adults: partial update of CG43. National Clinical Guideline Centre (UK). 2014.

    Google Scholar 

  11. Look AHEAD Research Group. Eight-year weight losses with an intensive lifestyle intervention: the look AHEAD study. Obesity (Silver Spring). 2014;22(1):5–13.

    Article  Google Scholar 

  12. Bray GA, Frühbeck G, Ryan DH. Management of obesity. Lancet. 387(10031):1947–56.

    Google Scholar 

  13. Unick JL, Neiberg RH, Hogan PE. Weight change in the fi rst 2 months of a lifestyle intervention predicts weight changes 8 years later. Obesity (Silver Spring). 2015;23:1353–6.

    Article  Google Scholar 

  14. Watson S, Woodside JV, Ware LJ. Effect of a web-based behavior change program on weight loss and cardiovascular risk factors in overweight and obese adults at high risk of developing cardiovascular disease: randomized controlled trial. J Med Internet Res. 2015;17(7):e177.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Stuart R. Behavioral control of overeating. Behav Ther. 1967;5:357–65.

    Article  Google Scholar 

  16. Association ACoCH. Task force on Practice Guidelines, Obesity Expert Panel, 2013. Expert panel report: guidelines (2013) for the management of overweight and obesity in adults. Obesity (Silver Spring). 2014;22(Suppl 2):S41–410.

    Google Scholar 

  17. Baker RC, Kirschenbaum D. Self-monitoring may be necessary for successful weight control. Behav Ther. 1993;24(3):377–94.

    Article  Google Scholar 

  18. Klem ML, Wing RR, MT MG. A descriptive study of individuals successful at long-term maintenance of substantial weight loss. Am J Clin Nutr. 1977;66(2):239–46.

    Article  Google Scholar 

  19. Mc Guire M, Wing RR, Klem ML. Behavioral strategies of individuals who have maintained long-term weight losses. Obes Res. 1999;7(4):334–41.

    Article  CAS  Google Scholar 

  20. Steinberg D, Tate D, Bennett G. The efficacy of a daily self-weogjomg weight loss intervention using smart scales and e-mail. Obesity (Silver Spring). 2013;21(9):1789–97.

    Google Scholar 

  21. Knowler WC, Barrett-Connor E, Fowler SE. Diabetes Prevention Program Research Group Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403.

    Article  CAS  PubMed  Google Scholar 

  22. Knowler WC, Fowler SE, Hamman RF. Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374(9702):1677–86.

    Article  PubMed  Google Scholar 

  23. Wadden TA, Berkowitz RI, Womble LG. Randomized trial of lifestyle modification and pharmacotherapy for obesity. N Engl J Med. 2005;353(20):2111–21120.

    Article  CAS  PubMed  Google Scholar 

  24. Wing RR, Tate D, Gorin A. A self-regulation program for maintenance of weight loss. N Engl J Med. 2006;355(15):1563–71.

    Article  CAS  PubMed  Google Scholar 

  25. Brownell KD. The LEARN program for weight management. Dallas: American Health Publishing Company; 2004. ISBN-10: 1878513419; ISBN-13: 978-1878513410

    Google Scholar 

  26. Alamuddin N, Wadden TA. Behavioral treatment of the patient with obesity. Endocrinol Metab Clin N Am. 2016;45(3):565–80.

    Article  Google Scholar 

  27. Kokkinos A, le Roux CW, Alexiadou K. Eating slowly increases the postprandial response of the anorexigenic gut hormones, peptide YY and glucagon-like peptide-1. J Clin Endocrinol Metab. 2010;95(1):333–7.

    Article  CAS  PubMed  Google Scholar 

  28. Avenell A Broom J, Brown TJ. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. Health Technol Assess. 2004;8(21):III–V.

    PubMed  Google Scholar 

  29. Foreyt JP, Johnston C. Behavior modification and cognitive therapy. In: Mechanick J, editor. Lifestyle medicine a manual for clinical practice. Cham: Springer International Publishing; 2016. Chapter 14, p. 129–34.

    Google Scholar 

  30. Perri MG, Limacher MC, Durning PE. Extended-care programs for weight management in rural communities: the treatment of obesity in undeserved rural settings (TOURS) randomized trial. Arch Intern Med. 2008;168(21):2347–54.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Heymsfield SB, Wadden T. Mechanisms, pathophysiology, and management of obesity. N Engl J Med. 2017;376(3):254–66.

    Article  CAS  PubMed  Google Scholar 

  32. Ryan D, Heaner M. Guidelines (2013) for managing overweight and obesity in adults. Obesity. 2014;22(suppl 2):S1–3.

    Article  PubMed  Google Scholar 

  33. Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med. 1995;332(10):621–8.

    Article  CAS  PubMed  Google Scholar 

  34. Das SK, Gilhooly CH, Golden JK. Long-term effects of 2 energy-restricted diets differing in glycemic load on dietary adherence, body composition, and metabolism in CALERIE: a 1-y randomized controlled trial. Am J Clin Nutr. 2007;85(4):1023–30.

    Article  CAS  PubMed  Google Scholar 

  35. Johnston BC, Kanters S, Bandayrel K. Comparison of weight loss among named diet programs in overweight and obese adults: a meta-analysis. JAMA. 2014;312(9):923–33.

    Article  CAS  PubMed  Google Scholar 

  36. Apovian CM, Aronne LJ, Bessesen DH. Pharmacological management of obesity: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(2):342–62.

    Article  CAS  PubMed  Google Scholar 

  37. Stegenga H, Haines A, Jones K, Wilding J. Identification, assessment, and management of overweight and obesity: summary of updated NICE guidance. BMJ. 2014;349:g6608. https://doi.org/10.1136/bmj.g6608.

    Article  PubMed  Google Scholar 

  38. Logue J, Thompson L, Romanes F. Scottish Intercollegiate Guidelines Network. Guidelines: management of obesity: summary of SIGN guideline. BMJ. 2010;340.; 7744(27):474–7.

    Google Scholar 

  39. Tsai AG, Wadden TA. The evolution of very-low-calorie diets: an update and meta-analysis. Obesity (Silver Spring). 2006;14(8):1283–93.

    Article  Google Scholar 

  40. Westman EC, Feinman RD, Mavropoulos JC. Low-carbohydrate nutrition and metabolism. Am J Clin Nutr. 2007;86:276–84.

    Article  CAS  PubMed  Google Scholar 

  41. Tobias DK, Chen M, Manson JE, Ludwig DS, Willett W, Hu FB. Effect of low-fat diet in-terventions versus other diet interventions on long-term weight change in adults: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2015;3(12):968–79.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Hall K. Prescribing low-fat diets: useless for long-term weight loss? Lancet Diabetes Endocrinol 2015; Published Online S2213-8587 (15) 00413-1.

    Google Scholar 

  43. Ludwig DS, Friedman MI. Increasing adiposity: consequence or cause of overeating? JAMA. 2014;311(21):2167–8.

    Article  CAS  PubMed  Google Scholar 

  44. Hall K, Bemis T, Brychta R. Calorie for calorie, dietary fat restriction results in more body fat loss than carbohydrate restriction in people with obesity. Cell Metab. 2015;22(3):427–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Hession M, Rolland C, Kulkarni U. Systematic review of randomized controlled trials of low-carbohydrate vs. low-fat/low-calorie diets in the management of obesity and its comorbidities. Obes Rev. 2009;10(1):36–50.

    Article  CAS  PubMed  Google Scholar 

  46. Franz MJ, VanWormer JJ, Crain AL. Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J Am Diet Assoc. 2007;107(10):1755–67.

    Article  PubMed  Google Scholar 

  47. Hall KD, Sacks G, Chandramohan D. Quantification of the effect of energy imbalance on bodyweight. Lancet. 2011;378(9793):826–37.

    Article  PubMed  Google Scholar 

  48. Sanghvi A, Redman LM, Martin CK. Validation of an inexpensive and accurate mathematical method to measure long-term changes in free-living energy intake. Am J Clin Nutr. 2015;102(2):353–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. MacLean PS, Wing RR, Davidson T. NIH working group report: innovative research to improve maintenance of weight loss. Obesity (Silver Spring). 2015;23(1):7–15.

    Article  Google Scholar 

  50. Sumithran P, Prendergast LA, Delbridge E. Long-term persistence of hormonal adaptations to weight loss. N Engl J Med. 2011;365(17):1597–604.

    Article  CAS  PubMed  Google Scholar 

  51. National Institute for Health and Clinical Excellence: Guidance. Obesity: identification, assessment and management of overweight and obesity in children, young people and adults. London: National Clinical Guideline Centre (UK). National Institute for Health and Care Excellence (UK); 2014. nice.org.uk/guidance/cg189.

  52. Ross R, Hudson R, Stotz PJ. Effects of exercise amount and intensity on abdominal obesity and glucose tolerance in obese adults: a randomized trial. Ann Intern Med. 2015;162(5):325–34.

    Article  PubMed  Google Scholar 

  53. National Institute for Health and Clinical Excellence (NICE). Obesity: the prevention, identification, assessment and management of overweight and obesity in adults and children. London: NICE; 2006. Available from url: http://guidance.nice.org.uk/CG43.

    Google Scholar 

  54. Slentz CA, Duscha BD, Johnson JL. Effects of the amount of exercise on body weight, body composition, and measures of central obesity: STRRIDE–a randomized controlled study. Arch Intern Med. 2004;164(1):31–9.

    Article  PubMed  Google Scholar 

  55. Hinkle W, Cordell M, Leibel R. Effects of reduced weight maintenance and leptin repletion on functional connectivity of the hypothalamus in obese humans. PLoS One. 2013;8:e5914.

    Article  CAS  Google Scholar 

  56. Rosembaum M, Hirsch J, Gallagher DA. Long-term persistence of adaptive thermogenesis in subjects who have maintained a reduced body weight. Am J Clin Nutr. 2008;88(4):906–12.

    Article  Google Scholar 

  57. Pucci A, Finer N. New medications for treatment of obesity: metabolic and cardiovascular effects. Can J Cardiol. 2015;31(2):142–52.

    Article  PubMed  Google Scholar 

  58. Nuffer W, Trujillo JM, Megyeri JA. Comparison of new pharmacological agents for the treatment of obesity. Ann Pharmacother. 2016;50(5):376–88.

    Article  CAS  PubMed  Google Scholar 

  59. Weintraub M, Sundaresan PR, Madan M. Long-term weight control study. II (weeks 34 to 104). An open-label study of continuous fenfluramine plus phentermine versus targeted intermittent medication as adjuncts to behavior modification, caloric restriction, and exercise. Clin Pharmacol Ther. 1992;51(5):595–601.

    Article  CAS  PubMed  Google Scholar 

  60. Sjöström L, Rissanen A, Andersen T. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet. 1998;352(9123):167–72.

    Article  PubMed  Google Scholar 

  61. Chanoine JP, Hampl S, Jensen C. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial. JAMA. 2005;293(23):2873–83.

    Article  CAS  PubMed  Google Scholar 

  62. Torgerson JS, Hauptman J, Boldrin MN. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care. 2004;27(1):155–61.

    Article  CAS  PubMed  Google Scholar 

  63. Smith SR, Weissman NJ, Anderson CM. Behavioral Modification and Lorcaserin for Overweight and Obesity Management (BLOOM) Study Group. Multicenter, placebo-controlled trial of lorcaserin for weight management. N Engl J Med. 2010;363(3):245–56.

    Article  CAS  PubMed  Google Scholar 

  64. Fidler MC, Sanchez M, Raether B, for the BLOSSOM Clinical Trial Group. A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial. J Clin Endocrinol Metab. 2011;96(10):3067–77.

    Article  CAS  PubMed  Google Scholar 

  65. Aronne LJ, Wadden TA, Peterson C. Evaluation of phentermine and topiramate versus phentermine/topiramate extended-release in obese adults. Obesity (Silver Spring). 2013;21(11):2163–71.

    Article  CAS  Google Scholar 

  66. Allison DB, Gadde KM, Garvey WT. Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP). Obesity (Silver Spring). 2010;20(2):330–42.

    Article  CAS  Google Scholar 

  67. Apovian CM, Aronne L, Rubino D, COR-II Study Group. A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II). Obesity (Silver Spring). 2013;21(5):935–43.

    Article  CAS  Google Scholar 

  68. Wadden TA, Foreyt JP, Foster GD. Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial. Obesity (Silver Spring). 2011;19(1):110–20.

    Article  CAS  Google Scholar 

  69. Astrup A, Carraro R, Finer N. Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide. Int J Obes (Lond). 2012;36(6):843–54.

    Article  CAS  Google Scholar 

  70. Gadde KM, Allison DB, Ryan DH. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial. Lancet. 2011;377(9774):1341–52.

    Article  CAS  PubMed  Google Scholar 

  71. Crane J, McGowan B. The GLP-1 agonist, liraglutide, as a pharmacotherapy for obesity. Ther Adv Chronic Dis. 2016;7(2):92–107.

    Article  CAS  PubMed  Google Scholar 

  72. Rueda-Clausen CF, Padwal RS, Sharma AM. New pharmacological approaches for obesity management. Nat Rev Endocrinol. 2013;9:467–78.

    Article  CAS  PubMed  Google Scholar 

  73. Giddens JM, Sheehan KH, Sheehan DV. The Columbia suicidality severity rating scale (C-SSRS): has the gold standard become a liability? Innov Clin Neurosci. 2014;11(9–10):66–80.

    PubMed  PubMed Central  Google Scholar 

  74. Khera R, Murad MH, Chandar AK. Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis. JAMA. 2016;315(22):2424.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Chang SH, Stoll CR, Song J. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis 2003–2012. JAMA Surg. 2014;149(3):275–87.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Schauer PR, Bhatt DL, Kirwan JP for the STAMPEDE Investigators. Bariatric surgery versus intensive medical therapy for diabetes – 5-year outcomes. N Engl J Med. 2017;376(7):641–51.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Arterburn DE, Weidenbacher H, Maciejewski ML. Association between bariatric surgery and long-term survival. JAMA. 2015;313(1):62–70.

    Article  CAS  PubMed  Google Scholar 

  78. Wang BC, Furnback W. Modelling the long-term outcomes of bariatric surgery: a review of cost-effectiveness studies. Best Pract Res Clin Gastroenterol. 2013;27(6):987–95.

    Article  PubMed  Google Scholar 

  79. Mechanick J, Youdim A, Jones DB. AACE/TOS/ASMBS guidelines clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society and American Society for Metabolic & Bariatric Surgery. Obesity (Silver Spring). 2013;21(0 1):S1–27.

    Article  CAS  Google Scholar 

  80. Mc Kinney L, Skolnik N, Chrusch A. Diagnosis and management of obesity. American Academy of Family Physicians. 2013. http://www.aafp.org/dam/AAFP/documents/patient_care/fitness/obesity-diagnosis-management.pdf.

  81. Nguyen NT, Masoomi H, Magno CP. Trends in use of bariatric surgery 2003–2008. J Am Coll Surg. 2011;213(2):261–6.

    Article  PubMed  Google Scholar 

  82. Funk LM, Jolles SA, Greenberg CC. Primary care physician decision making regarding severe obesity and bariatric surgery: a qualitative study. Surg Obes Relat Dis. 2016;12(4):893–901.

    Article  PubMed  Google Scholar 

  83. Pi-Sunyer FX, Aronne LJ, et al. The practical guide: identification, evaluation, and treatment of overweight and obesity in adults. Bethesda: National Heart, Lung, and Blood Institute; 2000.

    Google Scholar 

  84. Daniel S, Soleymani T, Garvey WT. A complications-based clinical staging of obesity to guide treatment modality and intensity. Curr Opin Endocrinol Diabetes Obes. 2013;20(5):377–88.

    Article  PubMed  PubMed Central  Google Scholar 

  85. Sharma AM, Kushner RF. A proposed clinical staging system for obesity. Int J Obes (Lond). 2009;33(3):289–95.

    Article  CAS  Google Scholar 

  86. Garvey WT. New tools for weight-loss therapy enable a more robust medical model for obesity treatment: rationale for a complications-centric approach. Endocr Pract. 2013;19(5):864–74.

    Article  PubMed  PubMed Central  Google Scholar 

  87. Beamish AJ, Olbers T, Kelly AS, Inge TI. Cardiovascular effects of bariatric surgery. Nat Rev Cardiol. 2016;13:730–43. https://doi.org/10.1038/nrcardio.2016.162.

    Article  PubMed  CAS  Google Scholar 

  88. Santini F, Busetto L, Cresci B, Sbraccia P. SIO management algorithm for patients with overweight or obesity: consensus statement of the Italian Society for Obesity (SIO). Eat Weight Disord. 2016;21:305–7. https://doi.org/10.1007/s40519-016-0279-3.

    Article  PubMed  PubMed Central  Google Scholar 

  89. Dixon JB, Zimmet P, Alberti KG. International Diabetes Federation Taskforce on Epidemiology and Prevention. Bariatric surgery: an IDF statement for obese type 2 diabetes. Diabet Med. 2011;28(6):628–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  90. Handelsman Y, Bloomgarden ZT, Grunberger G. American Association of Clinical Endocrinologists and American College of Endocrinology – clinical practice guidelines for developing a diabetes mellitus comprehensive care plan. Endocr Pract. 2015;21(Suppl 1):1–87.

    Article  PubMed  Google Scholar 

  91. American Diabetes Association. Standards of medical care in diabetes 2017. Diabetes Care. 2017;40(Supp 1):S11.

    Article  Google Scholar 

  92. Guo F, Moellering DR, Garvey WT. The progression of cardiometabolic disease: validation of a new cardiometabolic disease staging system applicable to obesity. Obesity. 2014;22(1):110–8.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ackermann, M.A. (2018). Medical Management of Obesity. In: Lutfi, R., Palermo, M., Cadière, GB. (eds) Global Bariatric Surgery . Springer, Cham. https://doi.org/10.1007/978-3-319-93545-4_35

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-93545-4_35

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-93544-7

  • Online ISBN: 978-3-319-93545-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics